Kuwait Rna Polymerases Market Size & Outlook, 2023-2030
Related Markets
Kuwait rna polymerases market highlights
- The Kuwait rna polymerases market generated a revenue of USD 0.5 million in 2023 and is expected to reach USD 1.2 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
- In terms of segment, mrna production was the largest revenue generating application in 2023.
- MRNA Production is the most lucrative application segment registering the fastest growth during the forecast period.
Rna polymerases market data book summary
| Market revenue in 2023 | USD 0.5 million |
| Market revenue in 2030 | USD 1.2 million |
| Growth rate | 12.5% (CAGR from 2023 to 2030) |
| Largest segment | Mrna production |
| Fastest growing segment | MRNA Production |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MRNA Production, Other Applications |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Promega, New England Biolabs, RayBiotech, Qiagen NV, Takara Bio Inc, Abnova, Worthington Enterprises Inc, MyBiosource, Sino Biological, Biovision, Calzyme, ArcticZymes Technologies, MBL International Corporation, BPS Bioscience Inc., Bio-Techne Corp, ABclonal |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.2% of the global rna polymerases market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa rna polymerases market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 3.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
RNA Polymerases Market Scope
RNA Polymerases Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ABclonal | View profile | 501-1000 | Wuhan, Hubei, China, Asia | https://abclonal.com/ |
| MBL International Corporation | View profile | 101-250 | Woburn, Massachusetts, United States, North America | https://www.mblintl.com/ |
| ArcticZymes Technologies | View profile | 11-50 | Tromsø, Troms, Norway, Europe | https://arcticzymes.com/ |
| Calzyme | View profile | 11-50 | San Luis Obispo, California, United States, North America | https://www.calzyme.com |
| Biovision | View profile | 51-100 | Milpitas, California, United States, North America | https://www.biovision.com |
| BPS Bioscience Inc. | View profile | 51-100 | San Diego, California, United States, North America | http://bpsbioscience.com |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| Abnova | View profile | 251-500 | Taipei, T'ai-pei, Taiwan, Asia | http://www.abnova.com/ |
| Worthington Enterprises Inc | View profile | 8200 | 200 Old Wilson Bridge Road, Columbus, OH, United States, 43085 | https://www.worthingtonindustries.com |
| MyBiosource | View profile | 11-50 | San Diego, California, United States, North America | https://www.mybiosource.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Sino Biological | View profile | 251-500 | Beijing, Beijing, China, Asia | http://www.sinobiological.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Kuwait rna polymerases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rna polymerases market will help companies and investors design strategic landscapes.
Mrna production was the largest segment with a revenue share of 80% in 2023. Horizon Databook has segmented the Kuwait rna polymerases market based on mrna production, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
- Kuwait RNA Polymerases Application Outlook (Revenue, USD Million, 2018-2030)
- Oligonucleotide synthesis
- Other Applications
- Biopharmaceutical Processing
- mRNA Production
Reasons to subscribe to Kuwait rna polymerases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait rna polymerases market databook
-
Our clientele includes a mix of rna polymerases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait rna polymerases market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait rna polymerases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait Application - Rna Polymerases Market, 2023 - 2030 (US$M)
Kuwait RNA Polymerases Market Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
